Northern Trust
DRUG

Northern Trust’s Bright Minds Biosciences DRUG Stock Holding History

Northern Trust’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Buy
37,378
+11,808
+46% +$950K ﹤0.01% 2807
2025
Q4 		$2M Sell
25,570
-1,643
-6% -$110K ﹤0.01% 3002
2025
Q3 		$1.65M Buy
27,213
+1,587
+6% +$61.6K ﹤0.01% 3138
2025
Q2 		$669K Buy
+25,626
New +$768K ﹤0.01% 3555

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust's DRUG Position: Q1 2026 in Review

Northern Trust increased its Bright Minds Biosciences (DRUG) stake by 46% in Q1 2026, buying an estimated $950K and bringing the position to 37,378 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2807.

Northern Trust first reported a position in DRUG in Q2 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Northern Trust held 37,378 shares of Bright Minds Biosciences worth $2.73M as of Q1 2026.
  • Northern Trust bought 11,808 Bright Minds Biosciences shares in Q1 2026, an estimated $950K.
  • Bright Minds Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2807 holding.
  • Northern Trust first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.